Active surveillance versus treatment in low-risk DCIS: Women’s preferences in the LORD-trialRenée Schmitz, Eveline M. A. Bleiker, Ellen G. Engelhardt et al.|European Journal of Cancer|2023Cited by 39
Preferences of Treatment Strategies among Women with Low-Risk DCIS and OncologistsDanalyn Byng, Wim H. van Harten, Valesca P. Retèl et al.|Cancers|2021Cited by 18
Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature ReviewRenée Schmitz, Ellen G. Engelhardt, Marja van Oirsouw et al.|Cancers|2022Cited by 15
The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch populationSena Alaeikhanehshir, Jelle Wesseling, Renée Schmitz et al.|Breast Cancer Research and Treatment|2023Cited by 7
DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCISEllen G. Engelhardt, Lotte Elshof, Renée Schmitz et al.|The Breast|2024Cited by 1